# History and Physical

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Friedrich Nietzsche (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI019-SYN
- Date: 2026-07-07
- Fictional facility: St. Posthumous Health Center
- Fictional author: Konrad Ellison-Mbatha, MD
- Calendar frame: modern shifted

## Reason for visit

Establishing primary care for frequent disabling headaches with nausea and light sensitivity: headache history and red-flag screen, a headache diary, disability and mood screening, the daily combination tablets, MRI and syphilis serology, his eyes and his sleep. **S**

## Historical basis

- Friedrich Nietzsche was born on October 15, 1844, in Röcken, near Leipzig, where his father was a Lutheran minister. **D**
- His father, a Lutheran pastor, died in 1849, when his son was four, after about a year of seizures and progressive neurological deficits; an autopsy described "softening" of the brain. Nietzsche later wrote that his father died "in his six-and-thirtieth year"; medical accounts give his age as 36. The cause was not established. **D**
- He had severe myopia, worse in the right eye, and a right pupil larger than the left, both noted in early childhood; at about five an eye examination found that the right eye needed a very strong (six-dioptre) lens. By about 30 the right eye was functionally blind, and in 1878 an ophthalmologist found fluid in the right retina and diagnosed retinitis (central chorioretinitis). **D**
- Severe headaches began in his school years; at nine he was already missing school because of them. They were mainly right-sided, frontal and above the eye, came with sensitivity to light and with nausea and vomiting, and grew more severe in adult life. **D**
- In 1869, at 24, he was appointed to the chair of classical philology at Basel. Ill health led to sick leave in 1871 and again in 1876 to 1877, and in 1879 he resigned his professorship and received a small pension; he never held another post. **D**
- Looking back in 1888, he wrote that in 1879, in his "six-and-thirtieth year," he reached "the lowest point in my vitality," when "my eyes could distinguish nothing that lay three paces away from me"; he resigned at Basel, and the next winter, his "first winter in Genoa," he wrote Dawn "in the midst of the agony of a headache which lasted three days, accompanied by violent nausea." **D**
- After resigning he settled into a pattern of spending winters near the Mediterranean, usually in Italy, and summers in Sils Maria. After an unsuccessful spring taking the waters at Recoaro, he went to the Upper Engadine at the beginning of July 1881 and rented a modest room in Sils Maria, hoping the dry, sunny climate would relieve his headaches; he kept a strict daily schedule with five to seven hours of walking, filling notebooks as he went. **D**
- By his own admission he had gonorrhea twice in his twenties; whether either infection was in fact syphilis could not have been told apart reliably at the time. **D**

9 later historical claims are omitted because they describe events after the index age. See the teaching note.

These claims are historical evidence, not findings from a real modern examination.

## History of present illness

This fictional modern episode addresses the presenting concerns below. **S**

- Headaches on most days that stop him reading and writing, despite moving between climates to escape them. **S**
- He fears that a brain illness like the one that killed his father may lie behind the headaches. **S**
- Very poor sight in the right eye and tired eyes when reading. **S**
- Short, broken sleep. **S**

## Strengths and supports

- Engagement in care and meaningful activity **S**

## Medications and allergies

- Butalbital 50 mg, acetaminophen 325 mg and caffeine 40 mg oral tablet, one or two tablets as needed for headache, taken on about 16 days a month, up to four tablets a day (prescribed abroad) **S**
- Ibuprofen 200 mg oral tablet, two tablets as needed for headache on days without the combination tablets, about 4 days a month (over the counter) **S**
- No known allergy **S**

## Past medical history

True biography with historical dates; these events are not part of the synthetic care timeline.

- early childhood: Severe myopia, much worse in the right eye, and a right pupil larger than the left, both noted in early childhood **D** (CLM-0003)
- from about age nine: Severe headaches since his school years, mainly right-sided, with light sensitivity, nausea and vomiting, growing more severe in adult life **D** (CLM-0004)
- in his twenties: Gonorrhea twice in his twenties, by his own account **D** (CLM-0010)
- 1878: Right eye found almost blind, with fluid in the retina, diagnosed as retinitis **D** (CLM-0003)
- 1879: Left his university post for ill health after repeated sick leaves **D** (CLM-0005, CLM-0006)

## Procedures and immunizations

- No procedures before this visit. **S**


## Family history

- father: Died at 35 or 36 after about a year of seizures and progressive neurological deficits; an autopsy described softening of the brain; cause not established in the cited sources **D** (CLM-0002)

## Measurements

MIDAS 1, work days missed: 14 d; MIDAS 2, work days at half productivity or less: 22 d; MIDAS 3, household work days missed: 8 d; MIDAS 4, household days at half productivity or less: 12 d; MIDAS 5, family, social or leisure days missed: 18 d; PHQ-9: 7; GAD-7: 6; AUDIT-C: 1. All results are synthetic.

BP 118/76 mmHg; pulse 68 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 66 kg; BMI 21.8 kg/m². All vital signs are synthetic.

## Examination

Mental status: Alert, courteous and precise, with a dry humor; speech normal; mood tired and frustrated by lost working days; thought organized; PHQ-9 7 with item 9 scored 0, GAD-7 6; no thoughts of self-harm. Functional status: Independent in all activities. On headache days he cannot read or write and lies in a darkened room, often vomiting; on other days he can read for about an hour at a time before his eyes tire. Headache disability: MIDAS 74 (grade IV, severe) over the past three months; HIT-6 68 (severe impact). Physical examination is intentionally limited. **S**

## Assessment

1. Frequent disabling headaches on about 20 days a month, with nausea, vomiting and light sensitivity, mostly right-sided, since childhood and more frequent over the past year, with a combination headache tablet containing butalbital taken on about 16 days a month; under evaluation with a headache diary, MRI, syphilis serology and a headache medicine consultation; status draft. **S**
2. High myopia in both eyes, much worse in the right eye, since early childhood, with long-standing poor vision in the right eye and unequal pupils; comprehensive eye examination booked; status draft. **S**
3. Chronic insomnia, with difficulty falling asleep and early waking, worse on headache nights; no sleep medicine at intake; status draft. **S**

## Plan

- Diagnosis: a structured headache history, a red-flag screen (SNNOOP10) at every visit, a 14-day diary of headache days, attack features, triggers and every dose of acute medicine, and ICHD-3 criteria; MRI of the brain with and without contrast because the headaches have become more frequent over the past year, are strongly right-sided, and come with long-standing unequal pupils and a very poor right eye; treponemal and nontreponemal syphilis serology because of past gonorrhea, unequal pupils and poor vision. Guideline: Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (2018); The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice (2021); Choosing wisely in headache medicine: the American Headache Society's list of five things physicians and patients should question (2013); Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) **S**
- Neurology (headache medicine) consultation to confirm the diagnosis and advise on withdrawal of the overused tablets and on preventive treatment. Guideline: The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice (2021); Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update (2024); European Academy of Neurology guideline on the management of medication-overuse headache (2020) **S**
- Medication overuse at intake: explain how frequent combination tablets can keep headaches going; count every tablet and acute-medicine day in the diary; take no more than now and never more than four combination tablets a day until the consultation; no new sedatives or sleeping tablets. Guideline: Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (2018); European Academy of Neurology guideline on the management of medication-overuse headache (2020) **S**
- Comprehensive eye examination for high myopia: refraction, pupils, pressure, a dilated fundus examination for myopic degeneration, retinal breaks and lattice, and macular OCT; correction of the large difference between the eyes; the warning signs of retinal detachment and an Amsler grid; dilated examination every year. Guideline: Refractive Errors Preferred Practice Pattern (2023); Posterior Vitreous Detachment, Retinal Breaks, and Lattice Degeneration Preferred Practice Pattern (2025); Comprehensive Adult Medical Eye Evaluation Preferred Practice Pattern (2026) **S**
- Sleep: cognitive behavioral therapy for insomnia through the clinic's behavioral sleep program, a fixed rising time, a wind-down hour, and no sedative sleeping tablets. Guideline: Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline (2021) **S**
- Mood: PHQ-9 and GAD-7 at intake and at about two to three months, with direct questions about hopelessness and self-harm at each visit; a safety assessment if a score or answer calls for one. Guideline: CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); Depression and Suicide Risk in Adults: Screening (2023) **S**
- Reading, writing and walking: good light, large print and an enlarged screen, breaks every 30 minutes, voice dictation for long passages, sunglasses and a brimmed hat for glare, and his daily walks kept as a protected part of the plan. Guideline: The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice (2021); Refractive Errors Preferred Practice Pattern (2023) **S**

## Guideline basis

- Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (2018), International Headache Society (Cephalalgia 2018;38(1):1-211)
- The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice (2021), American Headache Society (Headache 2021;61(7):1021-1039)
- Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update (2024), American Headache Society (Headache 2024;64(4):333-341)
- European Academy of Neurology guideline on the management of medication-overuse headache (2020), European Academy of Neurology (European Journal of Neurology 2020;27(7):1102-1116)
- Choosing wisely in headache medicine: the American Headache Society's list of five things physicians and patients should question (2013), American Headache Society (Headache 2013;53(10):1651-1659)
- Sexually Transmitted Infections Treatment Guidelines, 2021 (2021), Centers for Disease Control and Prevention (MMWR Recommendations and Reports 2021;70(4):1-187)
- Refractive Errors Preferred Practice Pattern (2023), American Academy of Ophthalmology (Ophthalmology 2023;130(3):P1-P60)
- Posterior Vitreous Detachment, Retinal Breaks, and Lattice Degeneration Preferred Practice Pattern (2025), American Academy of Ophthalmology (Ophthalmology 2025;132(4):P163-P196)
- Comprehensive Adult Medical Eye Evaluation Preferred Practice Pattern (2026), American Academy of Ophthalmology (Ophthalmology 2026;133(4):P202-P236)
- Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline (2021), American Academy of Sleep Medicine (Journal of Clinical Sleep Medicine 2021;17(2):255-262)
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026), Aether Forge
- Depression and Suicide Risk in Adults: Screening (2023), U.S. Preventive Services Task Force
